Cite
TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque.
MLA
Johnston, Tom H., et al. “TC-8831, a Nicotinic Acetylcholine Receptor Agonist, Reduces l-DOPA-Induced Dyskinesia in the MPTP Macaque.” Neuropharmacology, vol. 73, Oct. 2013, pp. 337–47. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2013.06.005.
APA
Johnston, T. H., Huot, P., Fox, S. H., Koprich, J. B., Szeliga, K. T., James, J. W., Graef, J. D., Letchworth, S. R., Jordan, K. G., Hill, M. P., & Brotchie, J. M. (2013). TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque. Neuropharmacology, 73, 337–347. https://doi.org/10.1016/j.neuropharm.2013.06.005
Chicago
Johnston, Tom H., Philippe Huot, Susan H. Fox, James B. Koprich, Kendall T. Szeliga, John W. James, John D. Graef, et al. 2013. “TC-8831, a Nicotinic Acetylcholine Receptor Agonist, Reduces l-DOPA-Induced Dyskinesia in the MPTP Macaque.” Neuropharmacology 73 (October): 337–47. doi:10.1016/j.neuropharm.2013.06.005.